CME

Analyzing the Performance of CME Stock

Large-cap Finance company CME has logged a -2.7% change today on a trading volume of 3,157,670. The average volume for the stock is 2,026,564.

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. Based in Chicago, United States the company has 3,565 full time employees and a market cap of $86,263,455,744. CME currently offers its equity investors a dividend that yields 1.8% per year.

The company is now trading 1.19% away from its average analyst target price of $236.56 per share. The 16 analysts following the stock have set target prices ranging from $181.0 to $275.0, and on average give CME a rating of hold.

Over the last 52 weeks, CME stock has risen 11.1%, which amounts to a -20.6% difference compared to the S&P 500. The stock's 52 week high is $249.02 whereas its 52 week low is $190.7 per share. Based on CME's average net margin growth of 3.9% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%)
2023 5,578,900 3,226,200 57
2022 5,019,400 2,691,000 54
2021 4,689,700 2,636,400 56
2020 4,883,600 2,105,200 43
2019 4,868,000 2,115,800 43
2018 4,309,400 1,963,700 46
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS